IP Library Granted Patent US 10,494,421
Granted Patent B2
US 10,494,421 · App. 15/117,691 · Granted Dec 3, 2019

System, apparatus and method for biomolecules production

Inventor: José Castillo (Brussels, BE)
Assignee: UNIVERCELLS NV
C07K16/1027C12M21/14C12M21/18C12M23/52C12M29/04C12M29/10C12M47/12C07K2317/14
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,494,421
App. No.
15/117,691
Granted
Dec 3, 2019
Kind
B2
Abstract

An automated method for the production of cells and/or biomolecules such as protein or peptides includes culturing cells in at least one high cell density bioreactor, thereby fluidly connecting said bioreactor with a culture medium supply and a gas or gaseous mixture; fluidly connecting said bioreactor with a downstream unit; and growing cells to a density at least 50 million cells per ml. The total volume of the bioreactor is at least 10 liters. A system suitable for implementation of the automated method above is a small-scale and cupboard-sized system, which can be placed in a portable clean room.

Claims (15)

1. A system of producing antibodies and vaccines, comprising:

a cell culturing unit and a downstream unit which are fluidly connected to each other, said cell culturing unit comprises at least one perfusion bioreactor, which allows growing cells at a density of at least 50 million cells per ml, and a supplier is configured to supply said perfusion bioreactor with a cell medium and a gas or gaseous mixture, wherein a total volume of the perfusion bioreactor is in a range of 10 to 900 liters; and

a single supply line that provides the cell medium and the gas or gaseous mixture to the perfusion bioreactor;

wherein said system is implemented in a portable chamber, suitable for a portable clean room.

2. The system according to claim 1 , wherein the total volume of the perfusion bioreactor is in a range of 10 to 800 liters.

3. The system according to claim 1 , wherein said bioreactor further includes carriers.

4. The system according to claim 3 , wherein said carriers provide a cell growth surface of at least 1000 m2.

5. The system according to claim 1 , wherein said downstream unit comprises at least one element that is fluidly connectable with the perfusion bioreactor via a pluggable connection, said element being selected from the group consisting of a filter, a harvest, a dialyser, a biomolecule purifier and one protein concentration unit.

6. The system according to claim 1 , wherein the total volume of the bioreactor is in a range of 10 to 700 liters.

7. The system according to claim 1 , wherein the total volume of the bioreactor is in a range of 10 to 500 liters.

8. The system according to claim 1 , wherein the perfusion bioreactor does not include any port that provides the addition of the gas or gaseous mixture to the perfusion bioreactor apart from the single supply line.

9. A system of producing antibodies and vaccines, comprising:

a cell culturing unit and a downstream unit which are fluidly connected to each other, said cell culturing unit comprises at least one perfusion bioreactor, which allows growing cells at a density of at least 50 million cells per ml, and a supplier is configured to supply said perfusion bioreactor with a cell medium and a gas or gaseous mixture, wherein a total volume of the perfusion bioreactor is in a range of 10 to 900 liters; and

a single supply line that provides the cell medium and the gas or gaseous mixture to the perfusion bioreactor;

wherein the system is devoid of a recirculation loop.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 18, 2020
From: UNIVERCELLS S.A.
To: UNIVERCELLS TECHNOLOGIES S.A.
Reel/Frame 052682/0697 →
RELEASE OF SECURITY INTEREST Recorded Mar 12, 2020
From: EUROPEAN INVESTMENT BANK
To: UNIVERCELLS SA
Reel/Frame 052098/0631 →
SECURITY INTEREST Recorded Oct 14, 2019
From: UNIVERCELLS SA
To: EUROPEAN INVESTMENT BANK
Reel/Frame 050716/0598 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 10, 2016
From: CASTILLO, JOSÉ
To: UNIVERCELLS NV
Reel/Frame 039394/0139 →
Priority Claims (1)
EP 14154418 · Feb 10, 2014 · regional
Continuity (1)
Related Publication 20160355572A1 · Dec 8, 2016
Cited By (9)
US 1,099,116 US 12,209,689 US 12,234,441 US 12,359,170 US 12,460,168 US 12,570,960 US 12,655,377 US 12,662,653 US 12,698,468